Head and Neck Cancer Symposium - October 8, 2021
This symposium will bring basic scientists and clinicians together to discuss the latest developments in Head & Neck Cancer research and therapy.
Target Audience
Target audience:
- Otolaryngology / Head and Neck Surgery
- Medical Oncology
- Radiation Oncology
- Surgical Oncology
- Oral and Maxillofacial Surgery
- Oral and Maxillofacial Radiology
- Oral and Maxillofacial Pathology
- Dental Public Health
- Head & Neck Cancer Researchers
Learning Objectives
Upon completion of this activity, participants will be able to:
- Describe current research on the etiology, pathogenesis, metastasis and treatment of head and neck cancer;
- Apply innovative therapeutic approaches to the treatment of head and neck cancer patients with particular emphasis on immunotherapy and precision medicine;
- Identify the translational gap whereby advances in research are not translated into clinical applications that directly benefit patient health.
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this enduring activity for a maximum of 7.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 7.75 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 7.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 7.75 Participation
This educational activity is supported by an educational grant from GlaxoSmithKline.
This activity has been provided in part by an unrestricted educational grant from Medtronic.
This educational activity is supported by an educational grant from Olympus.